ARCHIVES

Duke Scores Highest On NCAB Review

This article is from The Cancer Letter archive.

Vol. 04 No. 28 | July 14, 1978

Download PDF Visit The Full Archive

Related Articles

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

“Imaginary Treatments,” “Wonderful Cures”

June 6, 1997

NCI-Approved Clinical Trials Listed For June 2001

July 27, 2001

Cancer Mmeetings Lister For Next Three Months

February 23, 1996

Herceptin Lowers Recurrence In Early Breast Cancer

November 25, 2005

The Cancer Letter Offers FAX Delivery

January 7, 1994